18 August 2026
Latham Advises Frazier Life Sciences on Private Placement Financing in Connection With Fulcrum Therapeutics and Slate Medicines Merger
Advising firms
Deal team
2 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Matt Bush Lead | Latham & Watkins LLP | Partner | corporate | San Diego |
| Anthony Gostanian | Latham & Watkins LLP | Counsel | corporate | Not stated |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 245m (US$245 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Fulcrum Therapeutics, Inc. (Target)
Slate Medicines, Inc. (Target)